Hemoperfusion cartridge - India CDSCO Medical Device Registration

Product Information

Hemoperfusion should be considered if: 1. After taking life threatening amounts of adsorbable drugs, deep coma and one of the following symptoms are observed: • hypoventilation • hypotonia • hypothermia • worsening of the clinical state despite conservative medical management; 2. the patient has taken drugs of which the amount, composition and kind are unknown and the patient is deeply comatose. The Adsorba has proven a high degree of efficacy for the following drugs: • barbiturates • organophosphates • bromocarbamide • paracetamol • ethchlorvynol • paraquat • meprobamate • phenacetin • methaqualone • salicylate The use of hemoperfusion as a supplementary treatment does not mean that other conventional methods of treatment should be omitted; measures such as gastric lavage, establishment of free airway and assisted respiration, controlled electrolyte and water balance, and forced diuresis should be administered whenever indicated. Futhermore it might be necessary to monitor carefully the blood levels of vital substances or drugs which also could be adsorbed during the hemoperfusion treatment. Access to the blood stream for hemoperfusion treatment can be obtained by normal hemodialysis methods